New drug karonudib tested in blood cancer patients
NCT ID NCT04077307
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase trial tests the safety of a new drug called karonudib in up to 9 adults with blood cancers like leukemia who have no standard treatment options left. The study aims to find a safe dose and look for any signs that the drug works. It is too early to know if karonudib will be effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
karonudib
What this could lead to
If successful, this could point toward a new treatment option for people with blood cancers who have run out of standard therapies.
What could go wrong
This is a very early, small trial with only 9 people, focused on safety. It may not show any benefit, and side effects are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aarhus University Hospital
RECRUITINGAarhus, Denmark
Contact
-
Karolinska University Hospital
RECRUITINGHuddinge, Sweden
Contact
Contact
-
Rigshospitalet Copenhagen University Hospital
RECRUITINGCopenhagen, Denmark
Contact
-
University Clinical Center Belgrade
RECRUITINGBelgrade, Serbia
Contact
-
University Clinical Center Kragujevac
RECRUITINGKragujevac, Serbia
Contact
-
Örebro University Hospital
RECRUITINGÖrebro, Sweden
Contact